Crucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. Crucell focuses on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide. Currently we are combating twelve major infectious diseases with our range of marketed vaccines.

Crucell's mission is to develop, produce and market vaccines and antibodies that prevent or treat infectious diseases.

Crucell's vaccine business provides stable and predictable sales and cash flow. In 2009, they sold more than 115 million vaccine doses in over 100 countries throughout the world, which makes them the largest independent vaccine player. Within vaccines they operate in three main markets: paediatric, travel & endemic, and respiratory.